Minor change to our valuation

19/04/24 -"Our new target price derives from the fine-tuning of the model. There have been no major changes to our EPS estimates (see the related comments). The change in the DCF is derived from the average net ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

19/04/24

Download

You may also be interested by these reports :

30/04/24

NEMETSCHEK GROUP

1Q24 first take: A solid start to the year – Full-year targets and ambition 2025 confirmed

26/04/24

CompuGroup Medical

1Q24 preview: Expecting a slow start to the year due to the tough comps of 1Q23

25/04/24

Dassault Systèmes

In Q1 24, software revenue growth (+7%) was in line with the low-end of the guidance but the growth structure differed. The recurring software ...

25/04/24

Temenos

We are seeing a downside risk to the full-year targets

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue